Topics
March 2012 | Perspectives: from The Editors Of New Retina Md
The Sunshine Act's Intimidation Factor
Will the noble objectives of this law set up a roadblock to innovation?
Richard S. Kaiser, MD, and Jonathan L. Prenner, MD
June 8, 2026
Alkeus Doses First Patient in Global Phase 3 NORTHSTAR Trial of Gildeuretinol for Stargardt Disease
FDA Issues Draft Guidance to Accelerate Development of Gene Therapies Using Existing Scientific Knowledge
June 5, 2026
Large International Study Finds No Link Between Semaglutide and Wet AMD Risk
June 4, 2026
NEI-Supported Researchers Launch Open-Access Tool to Expand Access to Amblyopia Care for Children
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
